Triple

T22878617
Position Surface form Disambiguated ID Type / Status
Subject Directive 2004/24/EC E567395 entity
Predicate alsoKnownAs P39 FINISHED
Object Traditional Herbal Medicinal Products Directive NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Traditional Herbal Medicinal Products Directive | Statement: [Directive 2004/24/EC, alsoKnownAs, Traditional Herbal Medicinal Products Directive]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Traditional Herbal Medicinal Products Directive
Context triple: [Directive 2004/24/EC, alsoKnownAs, Traditional Herbal Medicinal Products Directive]
  • A. European Pharmacopoeia
    The European Pharmacopoeia is a legally binding reference work that sets quality standards for medicines and their ingredients across member states of the Council of Europe.
  • B. Committee for Herbal Medicinal Products
    The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
  • C. Community code for medicinal products for human use
    The Community code for medicinal products for human use is a comprehensive European Union regulatory framework that harmonizes the authorization, supervision, and distribution of human medicines across EU member states.
  • D. Regulation (EC) No 141/2000 on orphan medicinal products
    Regulation (EC) No 141/2000 on orphan medicinal products is a key European Union law that establishes incentives and a special approval framework to encourage the development and marketing of medicines for rare diseases.
  • E. Therapeutic Products Act
    The Therapeutic Products Act is a Swiss federal law that regulates the authorization, monitoring, and safe use of medicines and medical devices in Switzerland.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Traditional Herbal Medicinal Products Directive
Target entity description: The Traditional Herbal Medicinal Products Directive is a European Union law that sets specific registration and safety requirements for traditional herbal medicines sold within the EU.
  • A. European Pharmacopoeia
    The European Pharmacopoeia is a legally binding reference work that sets quality standards for medicines and their ingredients across member states of the Council of Europe.
  • B. Committee for Herbal Medicinal Products
    The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
  • C. Community code for medicinal products for human use
    The Community code for medicinal products for human use is a comprehensive European Union regulatory framework that harmonizes the authorization, supervision, and distribution of human medicines across EU member states.
  • D. Regulation (EC) No 141/2000 on orphan medicinal products
    Regulation (EC) No 141/2000 on orphan medicinal products is a key European Union law that establishes incentives and a special approval framework to encourage the development and marketing of medicines for rare diseases.
  • E. Therapeutic Products Act
    The Therapeutic Products Act is a Swiss federal law that regulates the authorization, monitoring, and safe use of medicines and medical devices in Switzerland.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e24589d8348190b96422d13a678bc1 completed April 17, 2026, 2:36 p.m.
NER Named-entity recognition batch_69f17f5a26f4819086ede6d85a2ab2bf completed April 29, 2026, 3:47 a.m.
Created at: April 17, 2026, 3:39 p.m.